"Avadim is pioneering the way for skin and muscle science in sports medicine," said Peterson. "And to have them bring that expertise and innovation to a sports performance product like [pH]UEL 5.0™, is something truly special that I knew I wanted to be involved with. These products are transformational in every sense of the word."

No stranger to wear and tear on his body, Peterson made history this year, joining three Hall of Famers as the only players chosen for five NFL Pro Bowls before reaching the age of 26. He has earned All-Pro honors as both a cornerback and kick returner.

"We are thrilled to announce Patrick Peterson ('P2') as the initial spokesperson for our [pH]UEL 5.0™ product. Athletes experience maximum impact on their muscles and have minimal recovery time to bounce back," said Steve Woody, Chairman and CEO of Avadim. "Patrick embodies that truth, so it was a natural fit to have such a decorated and talented athlete like him join our family. [pH]UEL 5.0™ has been a 'well kept secret,' but that's about to change. We're confident that adding P2 will be a game changer for us."

About [pH]UEL 5.0™:[pH]UEL 5.0™, a division of Avadim Technologies Inc., is committed to making a difference by bringing highly differentiated technologies into the health and athletic space. [pH]UEL 5.0™ is a topical technology, formulated for the most difficult muscle integrity issues including muscle performance, muscle tightness, muscle recovery, muscle cramps, and flexibility. For more information, visit www.phuel5.com

About Avadim Technologies, Inc.:Avadim Technologies, Inc. is a life sciences company that has developed a new class of life science solutions based on Pathogenesis Based Therapies ("PBTs") that work to optimize the stratum corneum, integumentary functions, and the associated reactive tissue. Our platform of therapies works to protect and support natural physiological functions of the outer barrier of the body, to super normalize it, supporting treatments within the three series of therapies for infection prevention, neuromuscular disorders, and barrier repair. Our platform and technologies use a targeted topical delivery system, are non-toxic, and are effective without the side effects of other remedy approaches. Initial acceptance in the U.S. clinical market of our first PBTs and our novel preventative approach have shown both cost avoidance and superior effectiveness in addressing specific needs in healthcare. Avadim's advanced therapeutic class of Pathogenesis Based Therapies is capable of unlocking pathways to address emerging gaps in global health.

About Patrick Peterson:Patrick Peterson plays cornerback for the Arizona Cardinals of the National Football League. He was a first-round draft pick for the Cardinals in 2011, and recently signed a five-year extension of his contract to play with them through 2020. He has been voted into five straight Pro Bowls and is widely considered to be one of the league's very best.